Donor and recipient risk factor analysis of inferior postheart transplantation outcome in the era of durable mechanical assist devices

Clinical Transplantation
Marian UrbanGuy A MacGowan

Abstract

The study objective is to quantify the impact of donor and recipient variables on heart transplant survival in recipients with a significant proportion of implanted continuous-flow left ventricular assist devices (LVADs). This is a prospective cohort study of International Society for Heart and Lung Transplantation (ISHLT) Registry that includes all primary heart-alone transplants in adult recipients (January 2005 and June 2013, N = 15 532, 27% LVADs). Donor and recipient characteristics were assessed for association with death or graft failure within 90 days and between 90 days and 5 years after transplantation. On Cox proportional hazard model donor cause of death other than head trauma (hazard ratio [HR] 1.985, P < 0.0001), recipient congenital (HR 2.7555, P < 0.0001) and ischemic (HR 1.165, P = 0.0383) vs dilated etiology and female donor heart transplanted into male recipient (HR 1.207, P = 0.0354) were predictors of death or graft failure within 90 days. Between 90 days and 5 years, donor cigarette use (HR 1.232, P = 0.0001), recipient cigarette use (HR 1.193, P = 0.0003), diabetes (HR 1.159, P = 0.0050), arterial hypertension (HR 1.129, P = 0.0115), and ischemic vs dilative cardiomyopathy had an increased probability of ...Continue Reading

References

Sep 1, 2004·The Annals of Thoracic Surgery·Dipin GuptaSatoshi Furukawa
Mar 28, 2006·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Abdulaziz Al-KhaldiRobert C Robbins
Oct 22, 2008·Transplantation Proceedings·C I TsaoS S Wang
Oct 7, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Josef StehlikUNKNOWN Cardiac Transplant Research Database Group
Nov 19, 2011·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Eric S WeissAshish S Shah
Dec 20, 2011·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Jacqueline M SmitsAndreas Zuckermann
Mar 31, 2012·Transplantation Reviews·Bernhard FloerchingerStefan G Tullius
Nov 30, 2013·Transplant International : Official Journal of the European Society for Organ Transplantation·Marcus KutschmannNils R Frühauf
Feb 14, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K K KhushB A Goldstein
Jul 20, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Barbara Stella DoumourasHeather Joan Ross
Mar 6, 2017·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Henrik BergenfeldtJohan Nilsson
May 16, 2017·Heart & Lung : the Journal of Critical Care·Anne JalowiecConnie White-Williams
Aug 7, 2017·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Lars H LundUNKNOWN International Society for Heart and Lung Transplantation
Aug 22, 2017·The American Surgeon·Eno-Obong EssienDeborah M Stein
Mar 21, 2018·Texas Heart Institute Journal·Heidi J ReichFardad Esmailian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Lauren B CooperLars H Lund
Nihon Geka Gakkai zasshi
Soichiro KitamuraMasanobu Yanase
© 2022 Meta ULC. All rights reserved